---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-019797"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2021-08-13T23:59:59+00:00"
generated_at: "2026-06-29T11:57:40.992891+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Abeona Therapeutics appoints Edward Carr as CFO, effective August 10, 2021

## Summary
- Edward Carr, previously CAO, becomes CFO; continues as principal financial officer.
- Base salary of $400,000; annual bonus target of 40% of base salary.
- Receives 238,000 restricted stock units and options for 476,000 shares (10-year term).
- RSUs and options vest 25% on first anniversary, remainder over 36 months.

## SEC filing metadata
- accession: 0001493152-21-019797
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2021-08-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315221019797/0001493152-21-019797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315221019797/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-019797
- JSON: https://secwatch.observer/filing/0001493152-21-019797.json
- Plain text: https://secwatch.observer/filing/0001493152-21-019797.txt

## Key facts
- Executive change
  Edward Carr was appointed as Senior Vice President, Chief Financial Officer at ABEONA THERAPEUTICS INC..
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer
  source text: appointed Edward Carr, the Company’s Chief Accounting Officer, as Senior Vice President, Chief Financial Officer, effective on that same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315221019797/0001493152-21-019797-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.